NO903941L - ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DIAZEPINON DERIVATIVES. - Google Patents
ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DIAZEPINON DERIVATIVES.Info
- Publication number
- NO903941L NO903941L NO90903941A NO903941A NO903941L NO 903941 L NO903941 L NO 903941L NO 90903941 A NO90903941 A NO 90903941A NO 903941 A NO903941 A NO 903941A NO 903941 L NO903941 L NO 903941L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- lower alkyl
- diazepinon
- derivatives
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Det beskrives fremstilling av kondenserte diazepinoner med den generelle formel. hvor } (b) utgjør en av de toverdige restene. X er en =CH-gruppe eller et nitrogenatom, R er en lavere alkylrest, som dessuten eventuelt kan være substituert med fenyl som eventuelt er substituert med halogen, metyl eller metoksy, Rogutgjør hydrogen, halogen eller lavere alkyl, Rer hydrogen, klor eller metyl, Rog Rer lavere alkyl,. hvor Re dessuten også kan bety halogen, og m, n, o og p er. tallene 1 eller 2, idet summen m+n+o+p må være lik eller mindre enn 6. Forbindelsene utmerker seg ved høy selektivitet og egner seg som legemidler bl.a. til behandling av kolinergt betingede spasmer og motilitetsforstyrrelser.The preparation of condensed diazepinones of the general formula is described. where} (b) constitutes one of the divalent residues. X is a = CH group or a nitrogen atom, R is a lower alkyl radical, which may also be optionally substituted by phenyl which is optionally substituted by halogen, methyl or methoxy, Rye constitutes hydrogen, halogen or lower alkyl, R , Rog Rer lower alkyl,. where Re can also mean halogen, and m, n, o and p are. the numbers 1 or 2, as the sum m + n + o + p must be equal to or less than 6. The compounds are distinguished by high selectivity and are suitable as drugs, e.g. for the treatment of cholinergic spasms and motility disorders.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3930262A DE3930262A1 (en) | 1989-09-11 | 1989-09-11 | CONDENSED DIAZEPINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING THESE COMPOUNDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO903941D0 NO903941D0 (en) | 1990-09-10 |
| NO903941L true NO903941L (en) | 1991-03-12 |
Family
ID=6389152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90903941A NO903941L (en) | 1989-09-11 | 1990-09-10 | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DIAZEPINON DERIVATIVES. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0417631A3 (en) |
| JP (1) | JPH03209382A (en) |
| KR (1) | KR910006286A (en) |
| AU (1) | AU626452B2 (en) |
| CA (1) | CA2025005A1 (en) |
| DD (1) | DD299308A5 (en) |
| DE (1) | DE3930262A1 (en) |
| FI (1) | FI904469A0 (en) |
| HU (1) | HU206882B (en) |
| IL (1) | IL95622A (en) |
| NO (1) | NO903941L (en) |
| NZ (1) | NZ235270A (en) |
| PL (1) | PL165197B1 (en) |
| PT (1) | PT95259A (en) |
| RU (1) | RU2017740C1 (en) |
| YU (1) | YU47372B (en) |
| ZA (1) | ZA907199B (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3930266A1 (en) * | 1989-09-11 | 1991-03-14 | Thomae Gmbh Dr K | CONDENSED DIAZEPINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING THESE COMPOUNDS |
| ES2355157T3 (en) | 2002-07-05 | 2011-03-23 | Targacept, Inc. | N-ARILO DIAZASPIROCYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE OF THE SAME. |
| SE0202133D0 (en) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
| SE0303090D0 (en) | 2003-11-20 | 2003-11-20 | Astrazeneca Ab | Novel compounds |
| SE0303541D0 (en) | 2003-12-22 | 2003-12-22 | Astrazeneca Ab | New compounds |
| US8809552B2 (en) * | 2011-11-01 | 2014-08-19 | Hoffmann-La Roche Inc. | Azetidine compounds, compositions and methods of use |
| CN104364239B (en) * | 2012-06-13 | 2017-08-25 | 霍夫曼-拉罗奇有限公司 | Diaza spiro cycloalkane and azaspiro alkane |
| LT2900669T (en) | 2012-09-25 | 2019-11-11 | Hoffmann La Roche | Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases |
| AR095079A1 (en) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | DERIVATIVES OF OCTAHIDRO-PIRROLO [3,4-C] -PIRROL AND PIRIDINA-FENILO |
| CA2923523A1 (en) | 2013-11-26 | 2015-06-04 | F. Hoffmann-La Roche Ag | New octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl |
| UA118582C2 (en) | 2014-03-26 | 2019-02-11 | Ф. Хоффманн-Ля Рош Аг | Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| MX2016010675A (en) | 2014-03-26 | 2016-11-10 | Hoffmann La Roche | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors. |
| MA41898A (en) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | BICYCLIC QUINAZOLINONE DERIVATIVES |
| WO2017037146A1 (en) | 2015-09-04 | 2017-03-09 | F. Hoffmann-La Roche Ag | Phenoxymethyl derivatives |
| AU2016328436B2 (en) | 2015-09-24 | 2020-05-14 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual ATX/CA inhibitors |
| CA2991615A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
| AU2016328365B2 (en) | 2015-09-24 | 2020-04-23 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual ATX/CA inhibitors |
| WO2017050732A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
| CN110392679B (en) | 2017-03-16 | 2023-04-07 | 豪夫迈·罗氏有限公司 | Heterocyclic compounds useful as dual ATX/CA inhibitors |
| EP3596060B1 (en) | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | New bicyclic compounds as atx inhibitors |
| AU2018330423B2 (en) * | 2017-09-05 | 2023-04-06 | Neumora Therapeutics, Inc. | Vasopressin receptor antagonists and products and methods related thereto |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4210648A (en) * | 1977-05-31 | 1980-07-01 | Boehringer Ingelheim Gmbh | II-Aminoacyl-5,11-dihydro-6H-pyrido(2,3-B) (1,4)benzodiazepin-6-ones and salts thereof |
| DE3204153A1 (en) * | 1982-02-06 | 1983-08-11 | Dr. Karl Thomae Gmbh, 7950 Biberach | SUBSTITUTED THIENOBENZODIAZEPINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING IT |
| DE3204403A1 (en) * | 1982-02-09 | 1983-08-11 | Dr. Karl Thomae Gmbh, 7950 Biberach | NEW PYRIDOBENZODIAZEPINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
| IE55898B1 (en) * | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
| DE3726908A1 (en) * | 1987-08-13 | 1989-02-23 | Thomae Gmbh Dr K | NEW CONDENSED DIAZEPINONE, PROCESS FOR THEIR MANUFACTURE AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
| DE3930266A1 (en) * | 1989-09-11 | 1991-03-14 | Thomae Gmbh Dr K | CONDENSED DIAZEPINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING THESE COMPOUNDS |
-
1989
- 1989-09-11 DE DE3930262A patent/DE3930262A1/en not_active Withdrawn
-
1990
- 1990-09-05 EP EP19900117078 patent/EP0417631A3/en not_active Withdrawn
- 1990-09-10 CA CA002025005A patent/CA2025005A1/en not_active Abandoned
- 1990-09-10 NO NO90903941A patent/NO903941L/en unknown
- 1990-09-10 HU HU905852A patent/HU206882B/en not_active IP Right Cessation
- 1990-09-10 IL IL9562290A patent/IL95622A/en not_active IP Right Cessation
- 1990-09-10 DD DD90343932A patent/DD299308A5/en not_active IP Right Cessation
- 1990-09-10 YU YU171590A patent/YU47372B/en unknown
- 1990-09-10 PT PT95259A patent/PT95259A/en not_active Application Discontinuation
- 1990-09-11 FI FI904469A patent/FI904469A0/en not_active Application Discontinuation
- 1990-09-11 PL PL90286835A patent/PL165197B1/en unknown
- 1990-09-11 KR KR1019900014616A patent/KR910006286A/en not_active Application Discontinuation
- 1990-09-11 JP JP2241064A patent/JPH03209382A/en active Pending
- 1990-09-11 NZ NZ235270A patent/NZ235270A/en unknown
- 1990-09-11 ZA ZA907199A patent/ZA907199B/en unknown
- 1990-09-11 AU AU62352/90A patent/AU626452B2/en not_active Ceased
-
1992
- 1992-03-18 RU SU925011116A patent/RU2017740C1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| IL95622A (en) | 1994-04-12 |
| YU47372B (en) | 1995-01-31 |
| PL165197B1 (en) | 1994-11-30 |
| AU626452B2 (en) | 1992-07-30 |
| EP0417631A3 (en) | 1991-12-11 |
| NO903941D0 (en) | 1990-09-10 |
| YU171590A (en) | 1993-05-28 |
| KR910006286A (en) | 1991-04-29 |
| IL95622A0 (en) | 1991-06-30 |
| PL286835A1 (en) | 1991-08-26 |
| HU905852D0 (en) | 1991-03-28 |
| AU6235290A (en) | 1991-03-14 |
| JPH03209382A (en) | 1991-09-12 |
| EP0417631A2 (en) | 1991-03-20 |
| DE3930262A1 (en) | 1991-03-21 |
| ZA907199B (en) | 1992-05-27 |
| HU206882B (en) | 1993-01-28 |
| CA2025005A1 (en) | 1991-03-12 |
| NZ235270A (en) | 1991-11-26 |
| FI904469A0 (en) | 1990-09-11 |
| RU2017740C1 (en) | 1994-08-15 |
| HUT55393A (en) | 1991-05-28 |
| PT95259A (en) | 1991-05-22 |
| DD299308A5 (en) | 1992-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO903941L (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DIAZEPINON DERIVATIVES. | |
| NO175592C (en) | Analogous Process for the Preparation of Therapeutically Active Xanthines | |
| NO960713D0 (en) | Substituted azaindolylidene compounds and process for their preparation | |
| HK1063781A1 (en) | Pyrazole derivatives for treating hiv | |
| PT1023308E (en) | INHIBITORS OF NUCLEOSIDIC METABOLISM | |
| HUP0402225A2 (en) | Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them | |
| NO20050016L (en) | Diphenyllazetidinone derivatives for the treatment of lipid metabolism disorders | |
| FI943142A (en) | Amide and urea derivatives which counteract high blood cholesterol levels, their preparation and therapeutic uses | |
| PL285683A1 (en) | Method of obtaining novel amines | |
| NO20022124L (en) | Imidazopyridine derivatives as phosphodiesterase VII inhibitors | |
| NO944934L (en) | Inhibition of vasomotor symptoms and associated psychological disorders associated with post-menopausal syndrome | |
| NO178968C (en) | Analogous Process for Preparing Therapeutically Active Aminopyrimidine Carboxamide Derivatives | |
| NO933611L (en) | ANTI-TUMOR AND ANTI-PSORIATIC AGENTS | |
| NO944926L (en) | Methods for Inhibiting Myeloperoxidase Activity | |
| HUP9902683A2 (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms | |
| NO944924L (en) | Procedures for inhibiting Turner's syndrome | |
| NO944933L (en) | Procedure for inhibiting disease states of the breast | |
| GB8530507D0 (en) | Chemical compounds | |
| NO944931L (en) | Use of 2-phenyl-3-aroylbenzothiophenes for inhibiting early sexual maturity | |
| DE60318874D1 (en) | Pyrazolderivate | |
| ES2012736A6 (en) | Tricyclic 3-oxo-propanenitrile derivatives and process for their preparation. | |
| NO951433L (en) | Chemical connections | |
| DK661088A (en) | N- (23-VINBLASTINOYL) DERIVATIVES OF 1-AMINOMETHYLPHOSPHONIC ACID, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THEM | |
| NO904135L (en) | PROCEDURE FOR THE PREPARATION OF NEW SUBSTITUTED ALKYL PIPERIDINES AND THEIR USE AS INHIBITORS OF CHOLESTEROL SYNTHESIS. | |
| CA2266565A1 (en) | Azabicyclic rotomase inhibitors |